Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (281-290 of 425) with videos related to

Pageof 43
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|September 19, 2019
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trialsSilvia Fogacci, Federica Fogacci, Maciej Banach, et al.
International Journal of Cardiology|September 11, 2013
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?Dragana Nikolic, Maciej Banach, Shekoufeh Nikfar, et al.
Journal of Clinical Lipidology|August 1, 2015
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver diseaseAlper Sonmez, Dragana Nikolic, Teoman Dogru, et al.
Cephalalgia : an International Journal of Headache|May 11, 2017
The relationship between migraine and lipid sub-fractions among individuals without cardiovascular disease: A cross-sectional evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Alessandra C Goulart, Paulo A Lotufo, Itamar S Santos, et al.
Kidney International|March 13, 2018
Efficacy and safety of lipid lowering by alirocumab in chronic kidney diseasePeter P Toth, Jamie P Dwyer, Christopher P Cannon, et al.
Lipids in Health and Disease|February 14, 2016
Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboPeter P Toth, Sara C Hamon, Steven R Jones, et al.
Endocrinology|November 9, 2020
Unfavorable Triglyceride-rich Particle Profile in Subclinical Thyroid Disease: A Cross-sectional Analysis of ELSA-BrasilCarolina Castro Porto Silva Janovsky, Marcio Sommer Bittencourt, Alessandra C Goulart, et al.
Journal of Clinical Lipidology|October 21, 2019
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapyPeter P Toth, Harold E Bays, W Virgil Brown, et al.
Mayo Clinic Proceedings|March 24, 2025
Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysisMaciej Banach, Vikash Jaiswal, Song Peng Ang, et al.
Journal of Clinical Lipidology|August 21, 2019
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapyBrian C Case, Adam P Bress, Paul Kolm, et al.
Pageof 43

Showing results (281-290 of 425) with videos related to

Sort By:
Pageof 43
Clinical Nutrition (Edinburgh, Scotland)|September 19, 2019
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trialsSilvia Fogacci, Federica Fogacci, Maciej Banach, et al.
International Journal of Cardiology|September 11, 2013
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?Dragana Nikolic, Maciej Banach, Shekoufeh Nikfar, et al.
Journal of Clinical Lipidology|August 1, 2015
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver diseaseAlper Sonmez, Dragana Nikolic, Teoman Dogru, et al.
Cephalalgia : an International Journal of Headache|May 11, 2017
The relationship between migraine and lipid sub-fractions among individuals without cardiovascular disease: A cross-sectional evaluation in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Alessandra C Goulart, Paulo A Lotufo, Itamar S Santos, et al.
Kidney International|March 13, 2018
Efficacy and safety of lipid lowering by alirocumab in chronic kidney diseasePeter P Toth, Jamie P Dwyer, Christopher P Cannon, et al.
Lipids in Health and Disease|February 14, 2016
Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboPeter P Toth, Sara C Hamon, Steven R Jones, et al.
Endocrinology|November 9, 2020
Unfavorable Triglyceride-rich Particle Profile in Subclinical Thyroid Disease: A Cross-sectional Analysis of ELSA-BrasilCarolina Castro Porto Silva Janovsky, Marcio Sommer Bittencourt, Alessandra C Goulart, et al.
Journal of Clinical Lipidology|October 21, 2019
Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapyPeter P Toth, Harold E Bays, W Virgil Brown, et al.
Mayo Clinic Proceedings|March 24, 2025
Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysisMaciej Banach, Vikash Jaiswal, Song Peng Ang, et al.
Journal of Clinical Lipidology|August 21, 2019
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapyBrian C Case, Adam P Bress, Paul Kolm, et al.
Pageof 43